Methyl 4-(4-fluorophenyl)-3-oxobutanoate, 95+%, 500mg

N-(Chloroacetyl)-4-(trifluoromethyl)aniline, 97.0%, 100g

(1S,2R)-(-)-1-Amino-2-indanol>98.0%(GC)(T)1g

METHYL 4-BROMO-3-METHYLPICOLINATE, 95.0%, 250mg

TERT-BUTYL 2-(TERT-BUTOXYCARBONYLOXY)ETHYLCARBAMATE, 95.0%, 250mg

(R)-1-(5-Methylthiophen-2-yl)ethan-1-ol, 98%, 100mg

(2S,4R)-1-(tert-Butoxycarbonyl)-4-(4-fluorobenzyl)pyrrolidine-2-carboxylic acid, 95.0%, 2g

N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-N-methyl-L-valine>98.0%(HPLC)(T)1g

(4-Aminopiperidin-1-yl)(2,3-dihydrobenzo[b][1,4]dioxin-2-yl)methanone, 95%, 250mg

Valine, alanyl-, 98%, 250mg

Oculaire grand angle WF 15x/15 mm, tube Ø 30 mm

(5-Chloro-2-methoxypyridin-3-yl)methanamine hydrochloride, 95+%, 250mg

Methyl 4-(hydrazinylmethyl)benzoate hydrochloride, 97%, 250mg